FDA says Merck's (MRK -0.9%) vaccine to prevent cervical cancer, Gardasil, "continues to be safe...


FDA says Merck's (MRK -0.9%) vaccine to prevent cervical cancer, Gardasil, "continues to be safe and effective, and its benefits continue to outweigh its risks." Noting concerns over adverse effects, including death and Guillain-Barre Syndrome (GBS), FDA says none of the adverse events were at rates greater than expected. (FDA)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs